Ascendis Pharma A/S (ASND) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

Low Risk

Limited dilution potential

Last updated: February 12, 2025

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 0% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

61M

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

ASND currently has 60.7M outstanding shares. with minimal authorized share overhang for future dilution. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding
Feb 12, 2025	20-F filing \| 60.7M shares outstanding	61M
Feb 07, 2024	20-F filing \| 57.7M shares outstanding	58M
Feb 16, 2023	20-F filing \| 57.2M shares outstanding	57M
Mar 02, 2022	20-F filing \| 56.9M shares outstanding	57M
Mar 10, 2021	20-F filing \| 53.8M shares outstanding	54M
Apr 03, 2020	20-F filing \| 48.0M shares outstanding	48M

Back to ASND Details